Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVRI | Common Stock | Options Exercise | $39.3K | +25K | $1.57 | 25K | Jul 14, 2021 | Direct | F1 | |
transaction | EVRI | Common Stock | Sale | -$590K | -25K | -100% | $23.58 | 0 | Jul 14, 2021 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EVRI | Stock Option | Options Exercise | $0 | -25K | -25% | $0.00 | 75K | Jul 14, 2021 | Common Stock | 25K | $1.57 | Direct | F3 |
Id | Content |
---|---|
F1 | The transaction(s) reflected in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person on June 14, 2021 for options originally granted on May 11, 2016. |
F2 | The price reported in Column 4 of Table I is a weighted average price. The shares were sold in multiple transactions at a price ranging from $23.13 to $23.95. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F3 | Represents an option to purchase 100,000 shares of the Company's common stock, which vested in equal annual installments over a period of four years following the date of grant. |